मैगज़्टर गोल्ड के साथ असीमित हो जाओ
9,500 से अधिक पत्रिकाओं, समाचार पत्रों और प्रीमियम कहानियों तक असीमित पहुंच प्राप्त करें सिर्फ
कोशिश गोल्ड - मुक्त
New rules on biosimilars, gene therapy soon: DCGI
Mint Mumbai
|February 28, 2025
The Central Drugs Standard Control Organization (CDSCO) is in the process of creating guidelines to regulate cell and gene therapies and upgrading the framework to regulate biosimilars, as the Indian industry moves towards innovations in the space, Drugs Controller General of India (DCGI) Rajeev Raghuvanshi said on Thursday.
Raghuvanshi, who was speaking on the sidelines of the Indian Pharmaceutical Alliance's (IPA) Global Pharmaceutical Quality Summit 2025, said that while the country's top drug regulator had been focusing on operational efficiency, it's also looking closely at newer areas.
यह कहानी Mint Mumbai के February 28, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 9,500 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint Mumbai से और कहानियाँ
Mint Mumbai
Pricey variants after GST cuts? Govt keeps watch for mischief
The Centreis goingall out tostop companies from sidestepping the cutsin goods and services tax rates.
3 mins
September 24, 2025
Mint Mumbai
Forced exit at Tata Sons bares split at Tata Trusts
Vijay Singh’s ouster from Tata Sons follows some trustees feeling lack of transparency
5 mins
September 24, 2025
Mint Mumbai
Motorbike firms prep for quieter, electric future
Makers of electric motorcycles worldwide are touting stealth and instant power to convert those who swear by the rumble of a V-twin or the thump of a single-cylinder internal combustion engine.
3 mins
September 24, 2025
Mint Mumbai
How Nvidia is backstopping America’s AI boom
Nvidia’s move to invest $100 billion into Open AI to help finance a historic data center build-out has helped reset market expectations about the startup’s shaky finances.
3 mins
September 24, 2025
Mint Mumbai
J&J to withdraw acid reflux device outside US, alarming surgeons
Johnson & Johnson is withdrawing a device to treat debilitating acid reflux disease from markets outside the US, a move surgeons warned would set back the available treatment options for sufferers by more than a decade and also impact lung transplant patients.
3 mins
September 24, 2025
Mint Mumbai
War on spam call menace stalls on who takes blame
Blocking an unknown number or reporting a suspicious text message may feel like a small win against the spam menace.
3 mins
September 24, 2025
Mint Mumbai
Bear mark over IT signals more pain for investors
Investors in Indian IT companies saw their combined wealth plunge by over ₹1 trillion over the last two days. The pain may not be over yet.
2 mins
September 24, 2025
Mint Mumbai
Sebi, RBI plan easy int'l investor entry
The Securities and Exchange Board of India (Sebi) and the Reserve Bank of India (RBI) are in advanced discussions to ease entry processes for new overseas investors, four people aware of the matter said, at a time of weak foreign flows in the economy.
1 min
September 24, 2025
Mint Mumbai
Fortis to expand obesity clinics
Fortis Healthcare plans to open more dedicated obesity clinics across its hospitals to meet surging demand for weight-loss drugs and therapies in the world’s most populous nation, its managing director and chief executive, Ashutosh Raghuvanshi, said in an interview earlier this month.
1 min
September 24, 2025
Mint Mumbai
Why Sebi-registered advisers are dwindling despite eased norms
Shrinking number of Sebi-registered advisers means fewer options for investors seeking conflict-free advice
4 mins
September 24, 2025
Listen
Translate
Change font size